The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 02, 2021

Filed:

Jan. 26, 2018
Applicant:

University of Florida Research Foundation, Inc., Gainesville, FL (US);

Inventor:

Janet K. Yamamoto, Gainesville, FL (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/21 (2006.01); A61K 39/12 (2006.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01); C07K 16/10 (2006.01); A61K 45/06 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/21 (2013.01); A61K 39/12 (2013.01); A61K 45/06 (2013.01); C07K 14/005 (2013.01); C07K 16/1045 (2013.01); C07K 16/1054 (2013.01); C12N 7/00 (2013.01); G01N 33/56983 (2013.01); A61K 2039/552 (2013.01); A61K 2039/57 (2013.01); C07K 2317/31 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C12N 2740/15022 (2013.01); C12N 2740/15034 (2013.01); C12N 2740/16034 (2013.01); C12N 2740/16222 (2013.01); C12N 2740/16234 (2013.01); G01N 2333/52 (2013.01); G01N 2333/57 (2013.01);
Abstract

The subject invention concerns methods and materials for inducing an immune response in an animal or person against an immunodeficiency virus, such as HIV, SIV, or FIV. In one embodiment, a method of the invention comprises administering one or more antigens and/or immunogens to the person or animal wherein the antigen and/or immunogen comprises one or more evolutionarily conserved epitopes of immunodeficiency viruses. In one embodiment, the epitope is one that is conserved between HIV and SIV, or between HIV and FIV. In another embodiment, the epitope is one that is conserved between HIV, SIV, and FIV.


Find Patent Forward Citations

Yamamoto, Janet. (2021). Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats (U.S. Patent No. 10905757). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10905757

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…